Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christophe Lebouef"'
Autor:
Enrica Federti, Alessandro Matte, Antonio Recchiuti, Francesca Garello, Alessandra Ghigo, Wassim El Nemer, Enzo Terreno, Angela Amoresano, Domenico Mattoscio, Franco Turrini, Christophe Lebouef, Anne Janin, Antonella Pantaleo, Roberta Russo, Mickael Marin, Iana Iatcencko, Veronica Riccardi, Angela Siciliano, Achille Iolascon, Carlo Brugnara, Lucia De Franceschi
Publikováno v:
HemaSphere, Vol 7, Iss 3, p e848 (2023)
Drug repurposing is a valuable strategy for rare diseases. Sickle cell disease (SCD) is a rare hereditary hemolytic anemia accompanied by acute and chronic painful episodes, most often in the context of vaso-occlusive crisis (VOC). Although progress
Externí odkaz:
https://doaj.org/article/c8c05eebb53a44d484b867d2b88dc0d7
Autor:
Angela Siciliano, Giorgio Malpeli, Orah S. Platt, Christophe Lebouef, Anne Janin, Aldo Scarpa, Oliviero Olivieri, Eliana Amato, Roberto Corrocher, Yves Beuzard, Lucia De Franceschi
Publikováno v:
Haematologica, Vol 96, Iss 1 (2011)
Background Sickle cell disease, a genetic red cell disorder inherited in an autosomal recessive manner, occurs throughout the world. Hepatic dysfunction and liver damage may be present in sickle cell disease, but the pathogenesis of these conditions
Externí odkaz:
https://doaj.org/article/da81f3d69c9447d4b6e50c3302fc8c66
Autor:
Soo Young Choi, Anna Cozzi, Giorgia Federico, Sebastian Mueller, Davide Melisi, Tom Ganz, Narla Mohandas, Christophe Lebouef, Sonia Levi, Achille Iolascon, Luigia De Falco, Alberto Zamò, Francesca Carlomagno, I Silva, Mariasole Bruno, Dae Won Kim, Angela Siciliano, Enrica Federti, Carmine Carbone, Alessandro Matte, Anne Janin, Lucia De Franceschi
Publikováno v:
Antioxidants & redox signalling 28 (2018): 1–14. doi:10.1089/ars.2017.7051
info:cnr-pdr/source/autori:Matte A.; De Falco L.; Federti E.; Cozzi A.; Iolascon A.; Levi S.; Mohandas N.; Zamo A.; Bruno M.; Lebouef C.; Janin A.; Siciliano A.; Ganz T.; Federico G.; Carlomagno F.; Mueller S.; Silva I.; Carbone C.; Melisi D.; Kim D.W.; Choi S.Y.; De Franceschi L./titolo:Peroxiredoxin-2: A Novel Regulator of Iron Homeostasis in Ineffective Erythropoiesis/doi:10.1089%2Fars.2017.7051/rivista:Antioxidants & redox signalling/anno:2018/pagina_da:1/pagina_a:14/intervallo_pagine:1–14/volume:28
info:cnr-pdr/source/autori:Matte A.; De Falco L.; Federti E.; Cozzi A.; Iolascon A.; Levi S.; Mohandas N.; Zamo A.; Bruno M.; Lebouef C.; Janin A.; Siciliano A.; Ganz T.; Federico G.; Carlomagno F.; Mueller S.; Silva I.; Carbone C.; Melisi D.; Kim D.W.; Choi S.Y.; De Franceschi L./titolo:Peroxiredoxin-2: A Novel Regulator of Iron Homeostasis in Ineffective Erythropoiesis/doi:10.1089%2Fars.2017.7051/rivista:Antioxidants & redox signalling/anno:2018/pagina_da:1/pagina_a:14/intervallo_pagine:1–14/volume:28
Aims: Iron overload (IO) is a life-threatening complication of chronic hemolytic disorders such as ?-thalassemia. IO results in severe cellular oxidative damage, leading to organ failure. Peroxiredoxin-2 (Prx2), a typical 2-cysteine-(Cys)-peroxiredox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::767265da0637e78eddb0ac741f21c5ce
https://pubmed.ncbi.nlm.nih.gov/28793778
https://pubmed.ncbi.nlm.nih.gov/28793778
Autor:
Eliana Amato, Orah S. Platt, Roberto Corrocher, Anne Janin, Lucia De Franceschi, Oliviero Olivieri, Yves Beuzard, Angela Siciliano, Christophe Lebouef, Aldo Scarpa, Giorgio Malpeli
Background Sickle cell disease, a genetic red cell disorder inherited in an autosomal recessive manner, occurs throughout the world. Hepatic dysfunction and liver damage may be present in sickle cell disease, but the pathogenesis of these conditions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee20d7dcc2265b8c65e9f0ef75b8dfb3
http://hdl.handle.net/11562/345226
http://hdl.handle.net/11562/345226
